Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
The process is essentially the same as for bovine or porcine gelatin, except the starting material comes from horses
This could be due to a significant increase in interest in SARMs (Deconinck et al., 2021
Science-backed comparison of oral vs injectable BPC-157 for gut healing, systemic benefits, and injury recovery
:max_bytes(150000):strip_icc()/the-benefits-of-n-acetylcysteine-89416-primary-recirc-5a4235d9adfe45d19d276d024c537108.jpg)
US$ 27.38
US$ 22.01
US$ 20.67
